Advertising Policy
The International Journal of Emerging Advances in IVF and Assisted Reproduction is committed to maintaining the integrity, independence, and credibility of its scholarly content. Any advertising or promotional activity associated with the journal should be managed in a manner that does not compromise editorial decisions, peer review, research integrity, or the quality of published content.
1. Separation of Advertising and Editorial Content
Advertising, where accepted, should remain clearly separate from:
-
Editorial decisions
-
Manuscript evaluation
-
Peer review
-
Research findings
-
Publication decisions
-
Author selection
Advertisers should have no influence over the acceptance, rejection, revision, or publication of manuscripts.
2. Acceptable Advertising
The journal may consider advertising relevant to its academic, clinical, and professional audience, including advertisements related to:
-
Academic and scientific conferences
-
Medical and reproductive health research services
-
Clinical and fertility laboratory services
-
Scientific and medical equipment
-
Academic publishing services
-
Educational and professional programs
-
IVF and assisted reproductive technology services
-
Fertility and reproductive healthcare services
-
Embryology and reproductive medicine organizations
-
Relevant scientific, medical, and healthcare products and services
All advertising is subject to the journal's editorial and publishing requirements.
3. Prohibited or Inappropriate Advertising
The journal will not knowingly accept advertisements that are:
-
Misleading, deceptive, or fraudulent
-
Offensive, discriminatory, or inappropriate
-
Unlawful or contrary to applicable regulations
-
Inconsistent with scientific, medical, or professional standards
-
Likely to damage the journal's reputation or credibility
-
Presented as independent editorial or scholarly content
-
Designed to improperly influence authors, reviewers, editors, or editorial decisions
-
Making unsupported claims concerning fertility, IVF, assisted reproduction, or reproductive health
4. Healthcare and Reproductive Health Advertising
Advertising involving IVF treatments, assisted reproductive technologies, fertility treatments, reproductive healthcare services, fertility medications, diagnostic services, embryology services, laboratory services, reproductive genetic services, or healthcare claims should comply with applicable laws, regulations, ethical requirements, and professional standards.
Advertising should not make unsupported, misleading, exaggerated, or potentially harmful claims regarding the safety, effectiveness, quality, success rates, clinical outcomes, or benefits of a product or service.
5. Editorial Independence
Advertising revenue or promotional relationships must not influence:
-
Editorial policies
-
Peer-review outcomes
-
Manuscript acceptance or rejection
-
Publication priority
-
Research interpretation
-
Editorial appointments
The editorial team maintains independence from commercial and promotional interests.
6. Transparency
Advertisements should be clearly identifiable as advertising and should not be designed to resemble research articles, editorial content, peer-reviewed material, or other scholarly publications.
Where appropriate, commercial relationships should be disclosed transparently.
7. Review and Removal of Advertisements
The journal reserves the right to review, reject, modify, suspend, or remove advertisements that do not meet its requirements or that subsequently become inappropriate.
Acceptance of an advertisement does not constitute endorsement of the advertised product, treatment, service, company, or organization by the journal.
8. No Influence on Authors or Reviewers
Advertisers and commercial organizations must not receive confidential information about submitted manuscripts, reviewers, authors, research participants, or editorial decisions.
Confidential peer-review information will not be provided for advertising or promotional purposes.
9. Digital Advertising
Any advertising displayed on the journal's website should be clearly distinguishable from scholarly content. Digital advertisements should not interfere with the accessibility, readability, privacy, or integrity of published articles.
10. Commitment to Ethical Advertising
The International Journal of Emerging Advances in IVF and Assisted Reproduction aims to ensure that any advertising associated with the journal is handled responsibly, transparently, ethically, and independently, with priority given to the integrity of scholarly communication and the interests of readers and researchers over commercial interests.